Vivace Therapeutics

Vivace Therapeutics Overview

Founded 2014
Founded
Status Private
Employees 3
Employees
Latest Deal Type Series B
Latest Deal Amount $25M
Latest Deal Amount
Investors 5

Vivace Therapeutics General Information

Description

Developer of a small molecule drug discovery and development firm intended to bring novel therapies to treat cancer patients. The company's firm is built on innovative science in novel pathways and leverages research from leading academic laboratories by developing therapeutics that could work alone or in combination with other drugs, enabling patients to conquer cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2929 Campus Drive
  • Suite 150
  • San Mateo, CA 94403
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivace Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 28-Jun-2017 $25M 0000 0000 Completed Startup
1. Early Stage VC (Series A) 20-Jan-2015 0000 0000 0000 Completed Startup

Vivace Therapeutics Cap Table

To view Vivace Therapeutics‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000

Vivace Therapeutics Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Imara Formerly VC-backed Boston, MA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000 0000000000000 Venture Capital-Backed Chester, United Kingdom 00 000.00 00000000000 000.00
000000 00000000000 Corporation PA 000 000.00 00000000 000.00
00000000 Venture Capital-Backed Tübingen, Germany 000 00000 000000000000 00000

Vivace Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Sofie Qiao Ph.D President, Chief Executive Officer and Board Member
Bin Liu Ph.D Scientific Co-Founder
Andrei Konradi Ph.D Vice President & Head of Chemistry
Leonard Post Ph.D Chief Scientific Officer & Board Member
Kun-Liang Guan Ph.D Scientific Co-Founder

2 Former Executives

Vivace Therapeutics Board Members (6)

To view Vivace Therapeutics‘s full board member team, request access >>
Name Representing Role Since
Edward Hu Vivace Therapeutics Board Member 000 0000
Jun Wu Vivace Therapeutics Board Member 000 0000
Leonard Post Ph.D Self Chief Scientific Officer & Board Member 000 0000
Sofie Qiao Ph.D Vivace Therapeutics President, Chief Executive Officer and Board Member 000 0000
Tim Shannon Vivace Therapeutics Board Member 000 0000

1 Former Board Member

Vivace Therapeutics Investors (5)

To view Vivace Therapeutics‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cenova Capital Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
Mission Bay Capital Venture Capital Minority 000 0000 000000 0
WuXi Healthcare Ventures Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial